Deutsch English Français

Contact

EP3364949

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3364949

EP3364949 - CANCER VACCINES [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 03.06.2022 Database last updated on 30.10.2024
Former	Request for examination was made Status updated on 27.07.2018
Former	The international publication has been made Status updated on 28.04.2017
Most recent event Tooltip	13.09.2024	New entry: Renewal fee paid
Applicant(s)	For all designated states ModernaTX, Inc. 325 Binney Street Cambridge, MA 02142 / US
	[2024/29]
Former [2022/23]	For all designated states ModernaTX, Inc. 200 Technology Square Cambridge, MA 02139 / US
Former [2018/35]	For all designated states ModernaTX, Inc. 320 Bent Street Cambridge, MA 02141 / US
Inventor(s)	01 / VALIANTE, Nicholas 70 Norfolk Street Cambridge, MA 02139 / US
	02 / ZAKS, Tal 122 Bellevue Street Newton, MA 02458 / US
	03 / HUANG, Eric, Yi-Chun 90 Wareham Street Apartment 302 Boston, MA 02118 / US
	04 / CIARAMELLA, Giuseppe 1 Hawes Road Sudbury MA 01776 / US
	[2018/35]
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	[2018/35]
Application number, filing date	16858398.7	21.10.2016
	[2018/35]
	WO2016US58317
Priority number, date	US201562245031P	22.10.2015 Original published format: US 201562245031 P
	US201562245129P	22.10.2015 Original published format: US 201562245129 P
	US201562247472P	28.10.2015 Original published format: US 201562247472 P
	US201562247317P	28.10.2015 Original published format: US 201562247317 P
	US201662368810P	29.07.2016 Original published format: US 201662368810 P
	[2018/35]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2017070618
	Date:	27.04.2017
	Language:	EN
	[2017/17]
	Type:	A1 Application with search report
	No.:	EP3364949
	Date:	29.08.2018
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 27.04.2017 takes the place of the publication of the European patent application.
	[2018/35]
Search report(s)	International search report - published on:	AU	27.04.2017
	(Supplementary) European search report - dispatched on:	EP	01.07.2019
Classification	IPC:	A61K31/7105, A61K31/7115, A61K39/12, A61P31/14	[2019/31]
	CPC:	A61K39/0011 (EP,CN,US); A61K39/001114 (EP,CN,US); A61K9/10 (US); A61K9/5123 (EP,CN,US); A61P35/00 (EP,CN,US); A61K2039/53 (EP,CN,US); (+) A61K2039/545 (EP,CN,US); A61K2039/55588 (CN,US) (-)
	Former IPC [2018/35]	A61K9/10, A61K48/00, A61K39/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/35]
Extension states	BA	22.05.2018
	ME	22.05.2018
Validation states	MA	22.05.2018
	MD	22.05.2018
Title	German:	KREBSIMPFSTOFFE	[2018/35]
	English:	CANCER VACCINES	[2018/35]
	French:	VACCINS ANTICANCÉREUX	[2018/35]
Entry into regional phase	22.05.2018	National basic fee paid
	22.05.2018	Search fee paid
	22.05.2018	Designation fee(s) paid
	22.05.2018	Examination fee paid
Examination procedure	22.04.2018	Observations by third parties
	22.05.2018	Examination requested [2018/35]
	22.05.2018	Date on which the examining division has become responsible
	28.01.2020	Amendment by applicant (claims and/or description)
	08.06.2022	Despatch of a communication from the examining division (Time limit: M06)
	16.12.2022	Reply to a communication from the examining division
Fees paid	Renewal fee
	29.10.2018	Renewal fee patent year 03
	15.10.2019	Renewal fee patent year 04
	14.10.2020	Renewal fee patent year 05
	29.09.2021	Renewal fee patent year 06
	15.09.2022	Renewal fee patent year 07
	13.09.2023	Renewal fee patent year 08
	12.09.2024	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XI]WO9952503 (WAYNE JOHN CANCER INST [US]);
		[XI]CN1360025 (MILITARY MEDICAL UNIV NO 2 P L [CN]);
		[XI]WO2012159754 (BIONTECH AG [DE], et al);
		[XI]WO2013006837 (NOVARTIS AG [CH], et al);
		[A]WO2013143555 (BIONTECH AG [DE], et al);
		[XI]WO2014082729 (BIONTECH AG [DE], et al);
		[A]WO2015061467 (SHIRE HUMAN GENETIC THERAPIES [US], et al);
		[E]WO2017020026 (MODERNATX INC [US]);
	International search	[X]US2013156849 (DE FOUGEROLLES ANTONIN [US], et al);
		[X]US8754062 (DE FOUGEROLLES ANTONIN [US], et al);
		[X]WO2014144196 (SHIRE HUMAN GENETIC THERAPIES [US]);
		[A]WO2015130584 (MERCK SHARP & DOHME [US], et al);

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p